EUVIMEDEUVIMED entdecken
Crossref

Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors

Justine Benevent, Mélanie Araujo, Sudip Karki, Caroline Delarue-Hurault, Julie Waser, Isabelle Lacroix, Sarah Tebeka, Christine Damase-Michel

The Journal of Clinical Psychiatry · 2023

DOI: 10.4088/jcp.22m14734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, 2023. Verfasst von Justine Benevent und 7 weiteren Autor:innen. Beteiligte Einrichtung: REGARDs Network, Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, CERPOP INSERM UMR 1295 - SPHERE team, Faculté de M…. Hauptthemen laut MEDLINE: Serotonin and Noradrenaline Reuptake Inhibitors, Hypertension, Pregnancy-Induced. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Among antidepressants, serotonin-norepinephrine reuptake inhibitors (SNRIs) are particularly expected to increase the risk of hypertensive disorders of pregnancy (HDP) with regard to their biological mechanism. We aimed to evaluate the association between prenatal exposure to SNRI and HDP.

Methods

In EFEMERIS, a French database including pregnant women covered by the French Health Insurance System of Haute-Garonne (2004-2019), we compared the incidence of HDP among women exposed to SNRI monotherapy during the first trimester of pregnancy to the incidence among 2 control groups: (1) women exposed to selective serotonin reuptake inhibitor (SSRI) monotherapy during the first trimester and (2) women not exposed to antidepressants during pregnancy. We conducted crude and also multivariate logistic regressions.

Results

Of the 156,133 pregnancies, 143,391 were included in the study population, including 210 (0.1%) in the SNRI group, 1,316 (0.9%) in the SSRI group, and 141,865 (98.9%) in the unexposed group. After adjustment for depression severity and other mental conditions, the risk of HDP was significantly higher among women exposed to SNRIs (n = 20; 9.5%) compared to women exposed to SSRIs (n = 72; 5.5%; adjusted odds ratio [aOR] [95% CI] = 2.32 [1.28-4.20]) and to unexposed women (n = 6,224; 4.4%; aOR [95% CI] = 1.89 [1.13-3.18]).

Conclusion

This study indicated an increased risk of HDP in women treated with SNRIs versus women treated with SSRIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serotonin and Noradrenaline Reuptake InhibitorsHypertension, Pregnancy-InducedPregnancyFemaleHumansSelective Serotonin Reuptake InhibitorsNorepinephrineSerotonin

Substanzen

Selective Serotonin Reuptake InhibitorsNorepinephrineSerotoninSerotonin and Noradrenaline Reuptake Inhibitors

Autor:innen und Institutionen

  • REGARDs Network, Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, CERPOP INSERM UMR 1295 - SPHERE team, Faculté de Médecine Université de Toulouse, Toulouse, France.
  • Corresponding Author: Justine Benevent, PharmD, PhD, Faculté de Médecine, 37 allées Jules Guesde, 31000, Toulouse, France (justine.benevent@univ-tlse3.fr).
  • Université Paris Cité, INSERM UMR1266, Institute of Psychiatry and Neurosciences, Team 1, Paris, France (Tebeka); Department of Psychiatry, AP-HP, Louis Mourier Hospital, Colombes, France.

Zitieren

APA

Benevent, J., Araujo, M., Karki, S., Delarue-Hurault, C., Waser, J., Lacroix, I., Tebeka, S., & Damase-Michel, C. (2023). Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.22m14734

Vancouver

Benevent J, Araujo M, Karki S, Delarue-Hurault C, Waser J, Lacroix I, et al. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors. The Journal of Clinical Psychiatry. 2023. doi:10.4088/jcp.22m14734

BibTeX
@article{Benevent2023,
  author = {Benevent, Justine and Araujo, Mélanie and Karki, Sudip and Delarue-Hurault, Caroline and Waser, Julie and Lacroix, Isabelle and Tebeka, Sarah and Damase-Michel, Christine},
  title = {Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors},
  journal = {The Journal of Clinical Psychiatry},
  year = {2023},
  doi = {10.4088/jcp.22m14734}
}
Kostenlos starten →